These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2202853)

  • 1. [Role of a beta adrenergic blocking agent nadolol (corgard) in prevention of arterial hypertension: a 6-month treatment (cooperative study)].
    Metelitsa VI; Filatova NP
    Kardiologiia; 1990 May; 30(5):8-14. PubMed ID: 2202853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The results of the comparative study of nadolol, propranolol, prazosin and hydrochlorothiazide in patients with arterial hypertension in a 12-month stepped-plan treatment (cooperative research). The Working Group of the Cooperative Program to Study New Preparations in the Prevention of Arterial Hypertension. I. The research protocol and results of monotherapy].
    Metelitsa VI; Filatova NP
    Ter Arkh; 1991; 63(8):30-4. PubMed ID: 1792612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The results of the comparative study of nadolol, propranolol, prazosin and hydrochlorothiazide in patients with arterial hypertension in a 12-month stepped-plan treatment (cooperative research). The Working Group of the Cooperative Program to Study New Preparations in the Prevention of Arterial Hypertension. II. The results of combined therapy. Side effects. The reasons for dropouts. Conclusion].
    Metelitsa VI; Filatova NP
    Ter Arkh; 1991; 63(8):35-41. PubMed ID: 1792613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The comparative results of a short course of nadolol and propranolol treatment of arterial hypertension patients (cooperative research). The Working Group of the Cooperative Program for the Study of New Preparations in Preventing Arterial Hypertension].
    Ter Arkh; 1989; 61(12):30-6. PubMed ID: 2697955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Veterans Administration cooperative study on nadolol as monotherapy and in combination with a diuretic.
    Freis ED
    Am Heart J; 1984 Oct; 108(4 Pt 2):1087-91. PubMed ID: 6148868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hypotensive effect and tolerability of a short course of treatment with prazosin (pratsiol) and hydralazine (apressin) in a cooperative study of new drugs for the prevention of arterial hypertension].
    Kardiologiia; 1985 Jan; 25(1):23-8. PubMed ID: 3981857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial therapy of essential hypertension: diuretic or beta blocker?
    Finnerty FA
    J Fam Pract; 1980 Aug; 11(2):199-205. PubMed ID: 6106039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age and antihypertensive drugs (hydrochlorothiazide, bendroflumethiazide, nadolol and captopril).
    Freis ED
    Am J Cardiol; 1988 Jan; 61(1):117-21. PubMed ID: 3276117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment of essential hypertension with Nadolol and Hydrochlorothiazide: a two-year follow-up.
    El-Mehairy MM; Shaker A; Ramadan M; Hamza S; Tadros SS
    J Int Med Res; 1982; 10(2):87-91. PubMed ID: 6802691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of prazosin versus nadolol in combination with a diuretic.
    Okun R; Kraut J
    Am J Cardiol; 1984 Jan; 53(3):37A-39A. PubMed ID: 6141724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of long-term treatment with prazosin and its combination with nadolol on the levels of blood hormones of the hypophyseal- gonadal system in patients with hypertension].
    Gumbatov NB; Mustafaev II; Mamedova RN; Kasumova FZ; Karaev ME; Akhmedova ZG
    Kardiologiia; 1992 Mar; 32(3):37-40. PubMed ID: 1405209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal hemodynamic changes after beta-blocker-diuretic combination therapy in azotemic hypertensive patients.
    Zawada ET
    Int J Artif Organs; 1986 Nov; 9(6):405-12. PubMed ID: 2880810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prazosin-new hypertensive agent. A double-blind crossover study in the treatment of hypertension.
    Schirger A; Sheps SG
    JAMA; 1977 Mar; 237(10):989-91. PubMed ID: 13230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Change in the spectrum of lipids and apoproteins A1 and B as affected by hypothiazide and pratsiol in patients with hypertension].
    Oganov RG; Mustafaev II; Perova NV; Postol'nikov SF; Metel'skaia VA
    Kardiologiia; 1985 Aug; 25(8):17-22. PubMed ID: 4068453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term treatment of essential hypertension using nadolol and hydrochlorothiazide combined.
    El-Mehairy MM; Shaker A; Ramadan M; Hamza S; Tadros SS
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):199S-203S. PubMed ID: 37875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nadolol and propranolol in the treatment of hypertension: a double-blind comparison.
    El Mehairy MM; Shaker A; Ramadan M; Hamza S; Tadros SS
    J Int Med Res; 1980; 8(3):193-8. PubMed ID: 6104614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with nadolol in Nigerian patients with essential hypertension.
    Iyun AO
    West Afr J Med; 1989; 8(1):18-28. PubMed ID: 2486767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone.
    Merkel C; Sacerdoti D; Bolognesi M; Enzo E; Marin R; Bombonato G; Angeli P; Gatta A
    Hepatology; 1997 Jul; 26(1):34-9. PubMed ID: 9214449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regression of left-ventricular myocardial hypertrophy in patients with hypertension during long-term treatment with beta-adrenergic blockaders].
    Shkhvatsabaia IK; Iurenev AP; Charyev KhE
    Kardiologiia; 1986 Mar; 26(3):28-33. PubMed ID: 2872357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.